Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies
Clinical trial NCT04640246 · UNKNOWN
Trial details
- NCT number
- NCT04640246
- Sponsor
- Taiga Biotechnologies, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2023-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.